Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours-Reference-Cited by-同舟云学术

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

Published:2009-08 Issue:2 Volume:71 Page:226-233
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

McCormack Ann I.,McDonald Kerrie L.,Gill Anthony J.,Clark Susan J.,Burt Morton G.,Campbell Kirsten A.,Braund Wilton J.,Little Nicholas S.,Cook Raymond J.,Grossman Ashley B.,Robinson Bruce G.,Clifton-Bligh Roderick J.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2008.03487.x/fullpdf

Reference42 articles.

1. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium;Daly;Journal of Clinical Endocrinology and Metabolism,2006

2. Malignant pituitary tumours;Kaltsas;Pituitary,1998

3. Clinical review: diagnosis and management of pituitary carcinomas;Kaltsas;Journal of Clinical Endocrinology and Metabolism,2005

4. Pituitary carcinoma: a clinicopathologic study of 15 cases;Pernicone;Cancer,1997

5. The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumours;Kaltsas;Journal of Clinical Endocrinology and Metabolism,1998

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment;Frontiers in Endocrinology;2024-02-02

2. Metastatic pituitary tumors: an institutional case series;Pituitary;2023-07-31

3. Clinical guidelines ‘Hyperprolactinemia’ (draft);Obesity and metabolism;2023-07-26

4. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas;Frontiers in Endocrinology;2023-07-17

5. Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review;Endocrine-Related Cancer;2023-02-27